Dr. Reddys Laboratories Ltd.

Dr. Reddys Laboratories is currently trading at Rs. 2672.05, up by 19.50 points or 0.74% from its previous closing of Rs. 2652.55 on the BSE.

The scrip opened at Rs. 2655.00 and has touched a high and low of Rs. 2691.60 and Rs. 2610.00 respectively. So far 34510 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2965.20 on 02-May-2019 and a 52 week low of Rs. 2060.00 on 30-Jul-2018.

Last one week high and low of the scrip stood at Rs. 2725.00 and Rs. 2555.55 respectively. The current market cap of the company is Rs. 44452.06 crore.

The promoters holding in the company stood at 26.76%, while Institutions and Non-Institutions held 44.50% and 14.44% respectively.

Dr. Reddy's Laboratories has reported 66.65% rise in its net profit at Rs 548.10 crore for the quarter ended June 30, 2019 as compared to Rs 328.90 crore for the same quarter in the previous year. Total income of the company increased by 12.35% at Rs 2980.10 crore for Q1FY20 as compared Rs 2652.50 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 42.09% in its net profit at Rs 676.50 crore for the quarter ended June 30, 2019 as compared to Rs 476.10 crore for the same quarter in the previous year. Total income of the company increased by 13.24% at Rs 4288.30 crore for Q1FY20 as compared Rs 3786.90 crore for the corresponding quarter previous year.